A Study of Compliance to Antiretroviral Therapy among HIV Infected Patients at a Tertiary Care Hospital in North Karnataka (2024)

  • Journal List
  • J Clin Diagn Res
  • v.10(5); 2016 May
  • PMC4948443

As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsem*nt of, or agreement with, the contents by NLM or the National Institutes of Health.
Learn more: PMC Disclaimer | PMC Copyright Notice

A Study of Compliance to Antiretroviral Therapy among HIV Infected Patients at a Tertiary Care Hospital in North Karnataka (1)

About UsAuthor ServicesArchiveSubmitJCDR

J Clin Diagn Res. 2016 May; 10(5): OC27–OC31.

Published online 2016 May 1. doi:10.7860/JCDR/2016/17948.7792

PMCID: PMC4948443

PMID: 27437267

Ishwar Siddappa Hasabi,1 Arun Beekanahalli Shivashankarappa,A Study of Compliance to Antiretroviral Therapy among HIV Infected Patients at a Tertiary Care Hospital in North Karnataka (2)2 Chandrashekar Kachapur,3 and Ram Suresh Kaulgud4

Author information Article notes Copyright and License information PMC Disclaimer

Abstract

Introduction

Compliance to Antiretroviral Therapy (ART) is a primary determinant of treatment success of HIV-AIDS. Many studies have shown inadequate compliance to ART in the Indian population.

Aim

To assess the compliance to ART among HIV infected patients, to explore the factors affecting compliance and impact of compliance on CD4 count.

Materials and Methods

A cross-sectional study was conducted with 200 adult patients attending ART center, KIMS, Hubli. The patients were randomly selected and compliance to ART over preceding 3 months was assessed. Reasons for non- compliance were assessed among those with inadequate compliance.

Results

Mean age of the study population was 40.07±9.99 years. The sex ratio was 1.02:1 (M:F). Majority of patients were in WHO stage 1 with treatment, with CD4 count above 500/μl. Pulmonary tuberculosis was the most common opportunistic infection.

Most of the patients were on long term ART, more than 5 years {81 (40.5%)}. Most of the patients were on ZLN regimen {97 (48.5%)}. Compliance over the preceding 3 months was 94.84± 14.93% for ART and 88.97±23.75% for opportunistic infection prophylaxis. There was no significant difference in compliance in relation to age group, sex, educational status, residence, religion, habits, HIV status of spouse or child, the regimen of ART and frequency of dosing. The compliance was better among those on long term treatment, i.e., those on treatment for more than 5 years compared to those who started ART in last 1 year (p=0.06). The most common reasons given by patients for non-compliance were going away from home, busy with other work and simply forgot. Better compliance was associated with higher CD4 count.

Conclusion

Compliance to ART was inadequate in the studied population, which is a major obstacle to success of ART.

Keywords: CD4 count, Compliance to medication, HIV-AIDS

Introduction

India is the second largely populated country in the world with a diverse set of social demographics. An estimated 34.0 million people were living with HIV as of 2011; 3.3 million of them were children under 15 years [1].

Four high prevalence states of South India (Andhra Pradesh, Karnataka, Tamil Nadu, Maharashtra) account for 53% of all HIV infections in our country [2].

Compliance to therapies is a primary determinant of treatment success of HIV-AIDS. Poor compliance attenuates optimum clinical benefits and therefore reduces the overall effectiveness of health systems [3].

Compliance to medication also known as ‘adherence with medications’ is the extent to which patient follows medical instructions [4]. In the treatment of patients with HIV infection it is essential to achieve more than 95% compliance to ART (Antiretroviral Therapy) in order to suppress viral replication and avoid the emergence of resistance. Many of the studies have shown that optimal compliance is 95% and compliance less than 95% is associated with virological failure rate of more than 50% [5]. Achieving such high rates of compliance is often difficult because the regimens include multiple and expensive medicines with complex dosing schedule which may cause multiple food interactions and adverse effects resulting in poor tolerability. In addition, lifestyle factors and patient–provider relationship has a significant impact on compliance. Considering these issues, a practical definition of compliance in the context of ART has been defined as ‘the extent to which a person’s behaviour in taking medication, following dietary specifications and/or executing lifestyle changes corresponds to the advised recommendations from a doctor/ healthcare provider’ [57].

Compliance to ART is the second strongest predictor of progression to AIDS and death, after CD4 count [8,9]. Inadequate compliance to ART, however, is common in all groups of treated individuals. The average rate of compliance to ART is approximately 70%, but long-term viral suppression requires near-perfect compliance [8].

A 10% improvement in compliance results in a 21% reduction in disease progression [10,11]. The various factors affecting compliance are social aspects like motivation to begin and adhere to therapy, socioeconomic status, educational status, financial status, family support, lifestyle pattern, advantages and disadvantages of starting therapy like tolerability of regimen, availability of drugs, regimens-pill burden, frequency of dosing, food requirements, convenience, toxicity and drug availability [10].

This study was undertaken to assess compliance of the patients to therapy among those registered at ART center, Karnataka Institute of Medical Sciences (KIMS), a government run tertiary hospital at Hubli, Karnataka.

Aim

To assess the compliance to ART among HIV infected patients, to identify the factors affecting compliance and impact of compliance on CD4 count.

Materials and Method

This was a hospital based observational cross-sectional study conducted at government run Tertiaty hospital, Karnataka, over a period of 2 month from June 2015 to July 2015. Two hundred patients were randomly selected, among those who fulfill the inclusion criteria and agree to participate in the study, after having explained the procedure in detail and obtaining a written informed consent.

Inclusion criteria: HIV Infected adults ≥ 18 years on treatment for atleast 3 months from ART center, KIMS, Hubli and willing to participate in the study.

Exclusion criteria: Those not giving willing to participate in the study.

Clearance from the Ethical committee of KIMS, Hubli was obtained. Pretested and structured proforma was used to assess the details of the patients, family history, duration since HIV is diagnosed, duration of ART initiation, type of regimen and frequency of dosing. The recent CD4 counts of all the patients were noted from register.

The compliance of the patient in each month for previous 3 months was assessed based on number of missed doses and number of pills remaining unconsumed. The number of pills remaining unused was noted for each patient. The compliance, expressed as percentage compliance in each month was calculated by dividing total number of pills taken in the month divided by total number of drugs expected to be taken, multiplied by 100. The, average of percentage compliance of preceding 3 months was calculated and considered for analysis

The ART register was used for the patients who were unable to recall details of previous months. Among the patients with non-compliance, the reasons for it were enquired.

Similarly compliance to opportunistic infection prophylaxis was assessed by enquiring the patient about number of doses/tablets they had missed and expressed as percentage compliance.

Statistical Analysis

Values were expressed in mean± S.D. and percentage. Statistical analysis was done using Chi-square test, Fisher-Exact test, unpaired t-test, ANOVA test in SPSS version 20. The p ≤0.05 was considered statistically significant.

Results

Mean age of our study population was 40.07±9.99 years. For males, it was 42.01±9.47 years and for females, it was 38.12±10.17 years. Both among males and females, HIV prevalence was highest among 31-40 years [Table/Fig-1]. The sex ratio was 1.02:1 (M:F) (101 male, 99 female). The distribution of the residence was 1.45: 1 (Urban: Rural). Majority of the patients were in WHO stage 1 with treatment [Table/Fig-2]. Majority had CD4 count above 500 cell/μl [Table/Fig-3]. Tuberculosis was the commonest opportunistic infection among them (18.5%), predominantly in the form of pulmonary tuberculosis (14%) [Table/Fig-4].

Open in a separate window

[Table/Fig-1]:

Age and sex distribution of patients.

[Table/Fig-2]:

Presentation in different stages of HIV.

Stage of HIVMaleFemaleTotal
T19396189
T2437
T3303
T4101
TOTAL10199200

Open in a separate window

[Table/Fig-3]:

CD4 count among patients studied.

CD4 count(cells per μl)No. of pt.Percentage (%)
< 5063.0
51-10063.0
101-2003216
201-3002311.5
301-4004321.5
401-5003718.5
>5005326.5
TOTAL200100.0

Open in a separate window

[Table/Fig-4]:

Opportunistic infections (present and past) among patients

Opportunistic infectionNo. of patientsPercentage (%)
1Tuberculosis3718.5
APulmonary tuberculosis2814.0
BTuberculous pleural effusion31.5
CTuberculous lymphadinitis42.0
DTuberculous meningitis10.5
EAdbominal tuberculosis10.5
2Pneumocystis Jeroveci Pneumonia (PJP)42.0
3Oral candidiasis52.5
4Tinea10.5
5Cryptococcal meningitis10.5
6Herpes zoster10.5
7Chronic diarrhoea21.0
TOTAL5125.5

Open in a separate window

The HIV positive status was found in 97 (48.5%) of spouse and 6 (3%) of children.

Interpretation of compliance to ART

Most of the patients were on long term ART, greater than 5 years {81 (40.5%)} [Table/Fig-5]. Most of the patients were on ZLN regimen {97 (48.5%)}. But, the patients who were recently started ART were commonly on TLE regimen [Table/Fig-6,​,77].

Open in a separate window

[Table/Fig-5]:

Duration of ART initiation among patients studied.

[Table/Fig-6]:

Compliance to ART.

Compliance at present monthCompliance in last monthCompliance 2 months backOverall compliance of preceding 3 monthsCompliance with opportunistic infection prophylaxis/ treatment
Mean96.0293.8993.4694.8488.97
Std. Deviation (S.D.)14.5418.6620.5314.9323.75

Open in a separate window

[Table/Fig-7]:

ART regimens of patients.

Regimen.No. of patients (%)Overall compliance
MeanS.D.S.E.
TLE83 (41.5%)95.2111.451.27
ZLN97(48.5%)93.9318.461.87
ZLE15(7.5%)96.985.101.32
TL.AZ5(2.5%)98.800.450.20
TOTAL20094.8414.931.05
p- value0.74

Open in a separate window

(TLE- Tenofovir, Lamivudine and Efavirenz, ZLN-Zudovudine, Lamivudine and Nevirapine, ZLE- Zudovudine, Lamivudine and Efavirenz, TL.AZ- Tenofovir, Lamivudine and Atazanavir)

The compliance over the period of preceding three months was studied and it was 94.84± 14.93% for ART drugs [Table/Fig-6]. 100% compliance all through the 3 months was found in 124 patients (62%). Compliance was optimal (≥ 95% as per national ART guidelines) in 162 patients (81%) and suboptimal in 38 (19%). Highest compliance was found in younger age group, i.e. 18-30 years (96.82±7.27%) and least among those more than 50 years (90.67±24.17). Compliance was better among female (95.79±11.38), compared to male (93.88±17.80%), but insignificant (p=0.3679). It was better among literates (95.47±15.54%) compared to illiterates (93.72±15.64%), but insignificant (p=0.779). Urban people had better compliance than to rural people. (95.16±14.97% v/s 94.37±14.95%, p= 0.7154).

Association between compliance and CD4 count: Mean CD4 count was very significantly lower among the patients with suboptimal compliance (75.12±26.45%) compared to those with optimal compliance (99.46±1.21%) p<0.0001). Better compliance was associated with higher CD4 count and those with lower compliance had lower CD4 count as shown in table. This indicates that compliance plays vital role in improving CD4 count. (p= 0.0036) [Table/Fig-8,​,99].

[Table/Fig-8]:

Comparison of groups with different CD4 counts with overall compliance by one-way ANOVA.

CD4NMeanS.DSE
<1001185.7330.339.15
100-2995690.5922.192.96
300-4998096.457.570.85
>5005398.783.390.47
Total20094.8414.931.06
p-value0.0036*

Open in a separate window

* Significant

Open in a separate window

[Table/Fig-9]:

Comparison of groups with different CD4 counts with overall compliance.

Association between compliance and duration of ART: The compliance was significantly better among those on treatment for more than 5 years compared to those on treatment for less than 5 years (p=0.021) [Table/Fig-10,​,1111].

[Table/Fig-10]:

Comparison of duration of ART with COM-OV scores by one-way ANOVA.

Duration of ARTNMeansS.DSE
<6 months1991.8820.024.59
6 months-1years1184.6127.668.34
1years- 3years4995.228.481.21
3years- 5 years4093.2118.182.87
>5years8197.4911.811.31
Total20094.8414.931.06
p-value0.0600

Open in a separate window

[Table/Fig-11]:

Comparison of compliance to ART between the patients on treatment for more than 5 years and those less than 5 years.

Duration of ART initiationMeanS.D.
< 5 years97.4911.81
≥5 years93.0316.53
p-value0.021

Open in a separate window

There was no significant difference in compliance in relation to age group, sex, educational status, residence, religion, habits, HIV status of spouse and child, the regimen of ART and frequency of dosing.

Compliance with opportunistic infection prophylaxis/ treatment: Compliance to opportunistic infection prophylaxis/ treatment was 88.97 ±23.75%, which is lower compared to that of ART [Table/Fig-12].

[Table/Fig-12]:

Compliance with opportunistic infection prophylaxis/ treatment.

Opportunistic infectionDrugsNo. of patientsCompliance (mean±S.D)
PJP prophylaxisCotrimoxazole-DS6388.97± 23.75
PJP treatmentCotrimoxazole-DS484.12±14.21
Tuberculosis treatmentATT under DOTS3100
Oropharyngeal candidiasisFluconazole3100

Open in a separate window

Opportunistic infection prophylaxis was received by 63 patients for PJP 1 for cryptococcal meningitis. 3 were on treatment for tuberculosis, 3 for oropharyngeal candidiasis.

Reasons for non-compliance:

The most common reason given by patients for non-compliance was ‘going away from home’. The other common causes were, ‘being busy with other work’ and ‘simply forgot’. Some of the patients had multiple reasons [Table/Fig-13].

[Table/Fig-13]:

Reasons for non-compliance to ART*

ReasonsNo. of patients giving the reason
1Went away from home23
2Were busy with other work13
3Simply forgot12
4Had a change in daily routine7
5Fell sick/ ill7
6Did not have knowledge/ was not told of dosing6
7Did not want others to notice taking drugs4
8Felt that the drug was toxic4
9Slept through dose timing3
10Ran out of pills3
11Felt good3
12Felt depression/ worthless2
13Problem taking pills as specified1

Open in a separate window

(*some of the patients had multiple reasons)

The compliance to PJP prophylaxis was lower than that for ART, reason being difficulty in taking Tab. Cotrimoxazole-DS at afternoon as they are busy with their work.

Adverse effects to ART

They were found in 19 patients, the common being hyperpigmentation due to Zudovidine and drowsiness due to Efavirenz [Table/Fig-14].

[Table/Fig-14]:

Adverse effects to ART among patients studied

Adverse effectsNo. of patientsPercentage
1.Anemia31.5
2.Drowsiness52.5
3.Fatigue10.5
4.Gastritis21
5.Hyperpigentation52.5
6.Lip discoloration10.5
7.Nevirapine reaction21
8.Pruritis10.5
9.Swelling of face & legs10.5

Open in a separate window

(some of the patients had multiple adverse effects).

Discussion

Several studies have been conducted to assess compliance to ART and the factor affecting it at various geographical regions. Our study assessed the compliance over previous 3 months and it was 94.84±14.93%. This is consistent with the study by Vivek Lal et al., conducted at Lok Nayak Hospital, New Delhi, in which 90% compliance was found over the previous four-day period [3]. The common reasons cited by patients for non-compliance in our study were ‘away from home’, busy with other work’ and ‘simply forgot.’ This is in consistent with the reasons in the above mentioned study. Several other studies like by Bangsberg DR et al., and Chesney MA et al., have also reported the commonest barriers to compliance were absent-mindedness/forgetfulness and being away from home [1113].

Bhattacharya M et al., studied compliance to ART and its correlates among HIV infected children at New Delhi and the mean compliance was 91.4% and range was 75-100% [14]. Long duration since ART initiation, low caregiver educational state, efavirenz-based ART regimens and female gender were associated with lower compliance. The rise in CD4 count after ART initiation was more marked in the high compliance group, with the difference in the two groups becoming statistically significant after 6 months of ART [14]. Although the mean compliance to ART in our study was similar to this study results, we did not find statistically significant difference in compliance in relation to gender, education status and ART regimens. Arunkumar De et al., assessed the factors affecting compliance to ART among HIV positive mothers and their infected children at Kolkota [15]. 56% of mothers and 65.8% of children showed good compliance to ART. The compliance to ART was lesser compared to western countries. The study showed that different socio- demographic factors, health system related factors, drug related factors and psychological factors influence the compliance. This study also shows that maternal compliance has a great influence on pediatric compliance [15].

N Joglekar et al., have done research on barriers to ART compliance in Maharashtra and have reported multiple barriers such as: (1) financial barriers, such as unemployment and economic dependence; (2) social barriers of attending family cultures, functions and rituals; (3) patient related barriers, such as their attitude towards medications and their social stigma; and (4) health- care related barriers long waiting period, poor doctor-patient relationship and inadequate counselling at ART centers [16].

Mamta Sharma et al., conducted a study at SMS hospital, Jaipur and found that 13% of patients were non-compliant to ART [17]. Elderly age, lower education status, unemployment and presence of co-infections were significantly associated with non-compliance. Sex of patients, their marital status, area of residence, family size, distance from ART center and type of ART regimen were not associated with non-compliance, similar to findings in our study. Common reasons stated by patients for non-compliance were moving out of station, forgetfullness, lack of accompanying person, not feeling well and busy in occupation or other day to day activities [17]. Same reasons were cited by non-compliant patients even in our study.

A multi-centric-prospective observational study conducted by ART adherence study group across 30 ART centres in India revealed suboptimal compliance in 24.5% of patients [18] and the determinants of suboptimal compliance were illiteracy, on ART for less than 6 months, male gender, tribals, those on efavirenz based regimen, anxiety, non-disclosure of HIV status to family members, neglect from friends, inadequate motivation for treatment, frequent change of residence, travel expenses, inadequate counselling. In our study 19% had suboptimal compliance, which is lesser compared to above multi-centric study [18]. In consistent with above study even in our study, suboptimal compliance was common among male, rural residence, those on lesser duration of treatment, but it was not statistically significant. In contrast to the above study, our study demonstrated compliance to be better with TLE regimen, compared to ZLN regimen, but not statistically significant.

A meta-analysis on compliance to ART in sub-Saharan Africa and North America reported the optimal compliance of 77% among African population and 55% among North American population [19].

A cross-sectional study by Visanou Hansana et al., in Lao People’s Democratic Republic (PDR) showed 60% of patients to have more than 95% compliance to ART. Reasons for non-compliance were being busy (97.0%), and being forgetful (62.2%). The reasons are similar to those in our study [20].

Conclusion

Compliance to ART was inadequate in the studied population, which is a major obstacle to success of ART. Similarly it is inadequate at many ART centers in India. Although compliance to ART in our study was better than that in other studies in India and abroad, it is still inadequate. HIV/AIDS control, being an important national health programme, it is by the health education and counselling on the importance of compliance to ART, that this major obstacle can be overcome. Adequate pre-ART counseling of patients and also their family members on drugs, their importance and consequences of inadequate compliance is needed. Major reasons for non-compliance being moving out of station, measures are to be taken to make drugs available to these patients at other ART centers on emergency basis. Better compliance is associated with better survival and effective outcome.

Acknowledgments

Dr. Shivaprasad T, Postgraduate in General Medicine, KIMS, Hubli. Mr. Adishesh Kaul, Undergraduate Medical student, KIMS, Hubli

Notes

Financial or Other Competing Interests

None.

References

[1] UNAIDS GLOBAL REPORT 2011 and http:/www.nacoonline.org

[2] NACO Annual Report 2012-2013. Chapter 2, page number 6 “current epidemiological status”

[3] Lal V, Kant S, Dewan R, Rai SK. Reasons for Non-adherence to Antiretroviral Therapy Among Adult Patients Receiving free Treatment at a Tertiary Care Hospital in Delhi. Indian Journal of Community Med. 2010;35(1):172–73. [PMC free article] [PubMed] [Google Scholar]

[4] Shah CA. Adherence to high activity antiretrovial therapy in pediatric patients infected with HIV: issues and intervention. Indian Journal of Pediatrics. 2007;74(1):55–60. [PubMed] [Google Scholar]

[5] Osterberg L, Blaschke T. Adherence to Medication. N Engl J Med. 2005;353:487–97. [PubMed] [Google Scholar]

[6] Stone VE, Hogan JW, Schuman P, et al. Antiretroviral regimen complexity, self reported adherence and HIV patients’ understanding of their regimen : survey of women in the HER study. J Acquir Immune Defic Syndr. 2001;28:124–31. [PubMed] [Google Scholar]

[7] Ajithkumar K, Neera PG, Rajani PP. Relationship between social factors and treatment adherence: A study from South India. Eastern Journal of Medicine. 2011-16;(2):147152. [Google Scholar]

[8] Machtinger EL, Bangsberg DR. Adherence to HIV Antiretroviral Therapy. HIV InSite Knowledge Base Chapter May 2005

[9] Garcia de Olalla P, Knobel H, Carmona A, Guelar A, Lopez-Colomes JL, Cayla JA. Impact of adherence and highly active antiretroviral therapy on survival in HIV-infected patients. J Acquir Immune Defic Syndr. 2002;30:105–10. [PubMed] [Google Scholar]

[10] Nischal KC, Khopkar U, Saple DG. Improving adherence to antiretroviral therap. Indian Journal of Dermatol Venereol Leprol. 2005;71(5):316–20. [PubMed] [Google Scholar]

[11] Bangsberg DR, Perry S, Charlebois ED, Clark RA, Roberston M, Zolopa AR, et al. Nonadherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS. 2001;15:1181–83. [PubMed] [Google Scholar]

[12] Chesney MA. Factors affecting adherence to antiretroviral therapy. Clin Infect Dis. 2000;30(Suppl 2):171–76S. [PubMed] [Google Scholar]

[13] Pontali E. Facilitating adherence to highly active antiretroviral therapy in children. Pediatr Drugs. 2005;7:137–49. [PubMed] [Google Scholar]

[14] Bhattacharya M, Dubey AP. Adherence to antiretroviral therapy and its correlates among HIV infected children at an HIV clinic in New Delhi. Ann Trop Paediatr. 2011;31(4):331–37. [PubMed] [Google Scholar]

[15] De A, Dalui A. Assessment of factors influencing adherence to Antiretroviral Therapy for a Human Immuno deficiency virus positive mothers and their infected children. Indian Journal of Medical Science. 2012;66:11–12. [PubMed] [Google Scholar]

[16] Joglekar N, Paranjape R, Jain R, et al. Barriers to ART adherence & follow ups among patients attending ART centers in Maharashtra, India. The Indian Journal of Medical Research. 2011;134(6):954–59. [PMC free article] [PubMed] [Google Scholar]

[17] Sharma M, Rathore M, Kashyap A, Kumar C. Non-compliance to antiretroviral therapy: road blocks and possible solutions. Indian Medical Gazette. April 2015 [Google Scholar]

[18] Joshi B, Chauhan S, Pasi A, et al. Level of suboptimal adherence to first line antiretroviral treatment and its determinants among HIV positive patients in India. Indian J Med Res. 2014;140:84–95. [PMC free article] [PubMed] [Google Scholar]

[19] Mills EJ, Nachega JB, Buchan I. Orbinski J, Attaran A, Singh S, Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. JAMA. 2006;296(6):679–90. [PubMed] [Google Scholar]

[20] Hansana V, Sanchaisuriya P, Durham J, Sychareun V, Chaleunvong K, Boonyaleepun S, et al. Adherence to Antiretroviral Therapy (ART) among People Living With HIV (PLHIV): a cross-sectional survey to measure in Lao PDR. BMC Public Health. 2013;13:617. [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical and Diagnostic Research : JCDR are provided here courtesy of JCDR Research & Publications Private Limited

A Study of Compliance to Antiretroviral Therapy among HIV Infected Patients at a Tertiary Care Hospital in North Karnataka (2024)
Top Articles
Latest Posts
Article information

Author: Rob Wisoky

Last Updated:

Views: 5241

Rating: 4.8 / 5 (48 voted)

Reviews: 87% of readers found this page helpful

Author information

Name: Rob Wisoky

Birthday: 1994-09-30

Address: 5789 Michel Vista, West Domenic, OR 80464-9452

Phone: +97313824072371

Job: Education Orchestrator

Hobby: Lockpicking, Crocheting, Baton twirling, Video gaming, Jogging, Whittling, Model building

Introduction: My name is Rob Wisoky, I am a smiling, helpful, encouraging, zealous, energetic, faithful, fantastic person who loves writing and wants to share my knowledge and understanding with you.